Chiome Bioscience Starts Phase I Trial of ADCT-701 in Neuroendocrine Tumors

Chiome 生物科學已開始在神經內分泌腫瘤中進行 ADCt-701 的一期臨床試驗。

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文